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Antioxidative Phytochemicals and Biomarkers
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ABSTRACT
Lipid peroxidation is known to be a free chain reaction which takes place both in vivo and in vitro, and forms lipid hydroperoxides and secondary products. These lipid peroxidation products are highly reactive and have been shown to interact with many
biological components such as proteins, amino acids, amines, phospholipids and DNAs. As novel biomarkers for early stage of
lipid peroxidation process, we have developed monoclonal antibodies specific to oxidatively modified lysines with linoleic acid-,
arachidonic acid- eicosapentanoic acid- and docosahexaenoic acid-hydroperoxides. We have also succeeded in construction of
novel biomarkers specific to overproduction of oxidative stress during inflammation process. Recently, we found more potent
antioxidative phytochemicals such as sesame lignans, astaxanthin and curcuminoids, especially, tetrahydrocurcumin , one of the
main metabolites and also produced by fermentation of yeast (D. hansenil) of curcumin. We have also succeeded in determining
many functional activities including extention of ageing process.
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BIOMARKERS FOR LIPID PEROXIDATION
Recently we have been involved in developing novel
type of evaluation systems for oxidative stress using
“antibody chip” by application of monoclonal antibodies
which are specific to the lipid hydroperoxide-modified
proteins, phopholipids and nucleic acids. At an early stage
of lipid peroxidation, the lipid hydroperoxide is formed and
then decomposed into several aldehydes. These reactive
aldehydes can easily react with proteins, nucleic acids, and
amino-phospholipids, accompanied by stable and unstable
adduct formation, however, our research has focused on the
lipid hydroperoxide-derived protein modification. One of
adducts, hexanoyl-lysine (HEL), has been detected in
atherosclerotic plaques using polyclonal and monoclonal
antibodies to HEL. Several amide-type adducts,
azelayl-lysine (AZL), succinyl-lysine (SUL), glutaroyllysine (GLL), and propanoyl-lysine (PRL), have been also
identified recently. Because these adducts are probably
generated from oxidation products of n-3 and/or n-6 FAs
with lysine residues, the simultaneous determination of all
adducts may be a useful fingerprint to make clear what
kinds of lipid are oxidized in vivo(1). The HEL has been
gradually used as one of the important biomarkers because
the antibody to HEL and an ELISA kit are commercially
available. More recently, we have succeeded in
immunological and chemical detection of N-(hexanoyl)
phosphatedylethanolamine and N-(hexanoyl)-phosphatedylserine in an oxidative model induced by carbon
tetrachloride(2), and we just started to apply these markers
for preparation of “Antibody chip”.
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On the other hand, PRL is a novel biomarker and
therefore, we prepared the monoclonal antibody against
PRL to evaluate the generation of PRL in vivo(3). Then, we
analyzed the relevance to aging and neurodegenerative
disease using this antibody because ithas been reported that
lipid peroxidation is promoted in the brain during aging and
the aging was one of the most important risk factor of
neurodegenerative diseases. Immunohistochemical detection
using anti-PRL antibody suggested that propanoylation was
generated in the hippocampus area and temporal lobe in the
brain of Alzheimer’s disease (AD) patients. Our recent data
suggests that PRL has the capacity of not only the useful
biomarker of AD but also trigger of pathological
degradation to lead to AD etiology although the detailed
examination is undergoing (Hisaka et al., in preparation).

BIOMARKERS FOR OXIDATIVE STRESS
FORMED DURING INFLAMMATION
We have also succeeded in construction of novel
biomarkers specific to oxidative stress formed during
inflammation process. Neutrophil myeloperoxidase (MPO)
generates hypochlorous acid (HOCl) and/or hypobromous
acid (HOBr) using hydrogen peroxide and Br-/Cl-. The
active halogenating species can modify proteins. The
modification of protein by the reactive intermediates causes
protein tyrosine halogenation forming chlorotyrosine (ClY)
or bromotyrosine (BrY)(4). MPO can catalyze dityrosine
(DY) formation in the presence of H2O2, and suggesting that
the DY may become one of universal protein oxidation
markers(5). We have immunochemically detected DY in
lipofuscin of pyramidal neuron of aged human brains and
the atherosclerotic lesion of apoE knockout mice. A
potential role of DNA damage by leukocyte-derived reactive
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Figure 1. Structures of antioxidative food factors.

oxygen species (ROS) in carcinogenesis has also been
suggested. Recently, we have succeeded in developing a
novel monoclonal antibody that recognizes the hypohalous
acid-modified DNA and found that the epitopes was
identified as novel N4,5-dihaloge- nated 2’-deoxycitidine
residues(6). We also succeeded to prepare the monoclonal
antibody specific to 8-halogenated dGs, 8-clorodeoxyguanosine (8-CldG) and 8-bromo-deoxyguanosine
(8-BrdG)(7). Using that antibody and liquid chromatography
tandem mass spectrometry (LC-MS/MS), our results
demonstrated facile formation of 8-halo-dGs in the liver and
urine of rats administered LPS. Furthermore, with respect to
the order of modification of dG, halogenation occurred prior
to oxidation and nitration, which may be useful for
evaluation of the progress of inflammatory diseases.

ANTIOXIDATIVE PHYTOCHEMICALS AND
BRAIN AGING
Advances in understanding the neurodegenerative
pathologies are creating new opportunities for the
development of neuroprotective therapies, such as
antioxidant food factors, lifestyle modification and drugs.
However, the biomarker by which to determine the effect of
the agent on neurodegeneration is limited. Recently, our
research group focused on hexanoyl dopamine (HED), one
of novel dopamine adducts derived from brain
polyunsaturated acid, referring to its in vitro formation,
potent toxicity to SH-SY5Y cells(8), and application to
assess the neuroprotective effect of antioxidative food
factors. Dopamine is a neurotransmitter and its deficiency is
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a characterized feature in Parkinson’s disease (PD), thereby
HED represents a new addition to understanding of
dopamine biology and pathophysiology of PD and a novel
biomarker for the assessment of neuroprotective therapies.
We have established an analytical system using for the
detection of HED and its toxicity to the neuroblstoma cell
line, SH-SY5Y cells. We particularly report here on
hexanoyl dopamine (HED), a dopamine modified adduct
derived from arachidonic acid, referring to its formation,
effect on SH-SY5Y cells and applications to investigate the
neuroprotective effect of antioxidant foods, such as
tocopherol, curcumin, sesame lignans and astaxanthin. We
have demonstrated that HED was present in rat brain and
toxic to the neuroblastoma SH-SY5Y cells, thereby
representing a novel biomarker for the assessment of
neuroprotective therapies against PD. By assessing the
protective effect of antioxidant food factors on HED
formation (Figure 1), sesaminol-6-catechol (SMLC) showed
the most significant inhibitive effect on the in vitro HED
formation(9)(Figure 2). We also recently found that SMLC
markedly prevented HED-induced ROS generation and cell
death in SH-SY5Y cells. In addition, SMLC was detected in
the brain of rats fed with SMLC-contained foods,
suggesting that it could cross brain-blood barrier (BBB) and
exhibit the neuroprotective effect in vivo(10). SMLC is one of
the main metabolites produced by p-450 during injestion of
sesame lignans, in particular, sesaminol glucosides. We have
investigated many biological activities of SMLC such as
protection of colon carcinogenesis by meaqsuring
modifying effect of dietary sesaminol glucosides on the
formation of azoxymethane-induced premalignant lesions of
rat colon(11), and also downreguration on the expression of
cell adhesion molecules (CAMs) in human umbilical vein
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Moreover, astaxanthin pretreatment significantly inhibited
apoptosis, mitochondrial abnormalities and intracellular
ROS generation occurred in DHA-OOH-treated cells. The
neuroprotective effect of astaxanthin is suggested to be
dependent upon its antioxidant potential and mitochondria
protection; therefore, it is suggested that astaxanthin may be
an effective treatment for oxidative stress-associated
neurodegeneration (17) .

Figure 2. Inhibitory effects on HED Formation o by antioxidative food factors.

Recently, we have been involved in investigation what
is the real active form of astaxanchin, and we found that cis
astaxanthin and especially 9-cis astaxanthin exhibits a
higher antioxidant activity in vitro compared to the all-trans
isomer.astaxanthin(18) (Figure 3). Until now, most of
research showed that active form of astaxanthin is
all-trans .astaxanthin, however, we speculated that 9-cis
astaxanthin must be the active form of astaxanthin although
the detailemore d examination must be carried out.
ANTIOXIDATIVE PHYTOCHEMICALS AND

EXTENTION OF AGING
Figure 3. Biological activity of isomers of astaxan-

endothelial cells (HUVECs) induced by tumor necrosis
factor-α (TNF-α)(12). Our research group has also found that
SMLC can be formed by fermentation using Aspergillus
saitoi(13).
Recently, much attention has been focused on many
biological activities of astaxanthin. It accumulates in the
skeletal muscles of mammals after oral administration and
may have a role in physiological muscle function. Our
research group investigated the effect of astaxanthin on
muscle metabolism during exercise and its effect on
endurance. Astaxanthin treatment accelerated the decrease
of body fat caused by training and the running time to
exhaustion was prolonged in the trained mice by astaxanthin.
Astaxanthin also decreased the oxygen uptake and
respiratory quotient during recovery after running compared
with mice on a normal diet. Elevation of the plasma lactate
level and consumption of glycogen were inhibited by
as-taxanthin when a single session of exercise was
performed. Colocalization of fatty acid translocase with
carnitine palmitoyltransferase I (CPT I) in skeletal muscle
was increased by astaxanthin. We also found that
hexanoyl-lysine (HEL) modification of CPT I was increased
by exercise, while astaxanthin prevented this increase.
These results suggested that astaxanthin promoted lipid
metabolism rather than glucose utilization during exercise,
We also
which led to improvement of endurance(14).
investigated the effect and the mechanism of astaxanthin on
reactive oxygen species (ROS)-mediated apoptosis in
dopaminergic SH-SY5Y cells(15). The treatment with DHA
hydroperoxide (DHA-OOH), ROS-inducing neurotoxin, led
to a significant decrease in viable dopaminergic SH-SY5Y
cells by MTT assay(16), whereas a significant protection was
shown while the cells were pretreated with astaxanthin.
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As other type of plant antioxidants, it was found that
curcumin (U1), main yellow pigment of Curcuma longa
(turmeric) has many interesting functional activities for
prevention of life-style rlated diseases such as cancer,
atherosclerosis and diabetes mellitus etc. Recently, we
found that U1 was converted to tetrahydrocurcumin (THU1),
one of the major metabolites produced during the absorption
through the guts and THU1 was observed in the serum. We
have also found that U1 can be metabolized to THU1 by
fermentation of yeast (D. hansenil) used for food industry.,
and succeeded in commercial production of “Fermented
Turmeric” which contains THU1 by collaboration between
industrial and academic sectors, and we tried many biological activities of THU1 including protective role against
atherosclerosis, carcinogenesis and diabetes mellitus using a
wide variety of evaluation systems both in vitro and in
vivo(19) .
However, the literature concerning the anti-aging
mechanism of THU1 is limited to a single survival study in
C57BL/J6 mice(20). Recently, we found that THC regulated
the nuclear localization of FOXO in cultured cells and
inhibited phosphorylation of protein kinase B (PKB)/Akt
kinase. Furthermore, genetic analyses in Drosophila
revealed that foxo and Sir2 mediated the effects of THU1 on
life span and the oxidative stress response. These results
suggest that THC regulates the oxidative stress response and
aging via an evolutionally conserved signaling pathway. The
O-type forkhead domain transcription factor (FOXO) is
involved in many biological processes such as aging, the
oxidative stress response, and growth regulation. FOXO
activity is tightly controlled within cells. In particular,
growth factor signaling pathways and the oxidative stress
response can both stimulate nuclear translocation of this
transcription factor. Here, we show that THU1 regulates the
oxidative stress response and aging via FOXO. In NIH3T3
cells, THC induced nuclear accumulation of FOXO4, a
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member of the FOXO family of transcription factors, by
inhibiting phosphorylation of protein kinase B (PKB)/Akt.
In both of Yeast and Drosophila, THU1 attenuated the
oxidative stress response, an effect that was blocked in a
foxo mutant background. THU1 also extended the life
span of Drosophila under normal conditions, and loss of
either foxo or Sir2 activity eliminated this effect. Based on
these results, THU1 may regulate the aging process via an
evolutionarily conserved signaling pathway that includes
both foxo and Sir2.
The O-type forkhead domain transcription factor
(FOXO) is involved in manybiological processes such as
aging, the oxidative stress response, and growth regulation.
FOXO activity is tightly controlled within cells. In
particular, growth factor signaling pathways and the
oxidative stress response can both stimulate nuclear
translocation of this transcription factor. Here, we show that
tetrahydrocurcumin (THC), a curcumin metabolite,
regulates the oxidative stress response and aging via FOXO.
In NIH3T3 cells, THC induced nuclear accumulation of
FOXO4, a member of the FOXO family of transcription
factors, by inhibiting phosphorylation of protein kinase B
(PKB)/Akt. In Drosophila melanogaster, THC attenuated
the oxidative stress response, an effect that was blocked in a
foxo mutant background. THC also extended the life span of
Drosophila under normal conditions, and loss of either foxo
or Sir2 activity eliminated this effect. Based on these results,
THC may regulate the aging process via an evolutionarily
conserved signaling pathway that includes both foxo and
Sir2(21)(Figure 4).
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Figure 4. Extention of life span by resberatrol and THU1.
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